GlassScriptPhysician profile
Gregory R Veillette
NPI 1508083817
$23,061.12
in general payments reported to CMS, 2019-2025
16 companies · $16K in 2025
The $16K reported for 2025 was more than what 94% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $14.50 · 2021: $3,335 · 2022: $131 · 2023: $1,206 · 2024: $2,238 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $5,509 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $782 · Education: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,500.00 |
| Food and Beverage | $5,509.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $781.93 |
| Education | $130.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $14,054.64 | 2023-2025 | Hemoblast Bellows |
| Medtronic, INC. | $6,196.05 | 2021-2025 | Signia, Endo Gia Ultra, Ligasure |
| Allergan, INC. | $573.75 | 2019-2022 | |
| Davol INC. | $479.93 | 2025 | Phasix Mesh |
| Transmedics, INC. | $439.00 | 2023 | Organ Care System |
| Abbvie INC. | $358.67 | 2023-2024 | Strattice Reconstructive Tissue Matrix Bps |
| W. L. Gore & Associates, INC. | $293.60 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Intuitive Surgical, INC. | $165.27 | 2023 | Da Vinci Surgical System |
| Kerecis Limited | $136.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $133.91 | 2024 | Novosorb Btm |
| Conmed Corporation | $83.33 | 2024 | Airseal |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Merck Sharp & Dohme LLC | $26.19 | 2023 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.33 | 2022 | |
| Olympus America INC. | $14.50 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $13.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Veillette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.